KvLQT3

Last updated

KCNQ3
Identifiers
Aliases KCNQ3 , BFNC2, EBN2, KV7.3, potassium voltage-gated channel subfamily Q member 3
External IDs OMIM: 602232; MGI: 1336181; HomoloGene: 20949; GeneCards: KCNQ3; OMA:KCNQ3 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001204824
NM_004519

NM_152923

RefSeq (protein)

NP_001191753
NP_004510

NP_690887

Location (UCSC) Chr 8: 132.12 – 132.48 Mb Chr 15: 65.86 – 66.16 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Kv7.3 (KvLQT3) is a potassium channel protein coded for by the gene KCNQ3. [5]

Contents

It is associated with benign familial neonatal epilepsy [6] and autism. [7] [8]

The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and one of two related proteins encoded by the KCNQ2 and KCNQ5 genes, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2). [5]

Interactions

KvLQT3 has been shown to interact with KCNQ5. [9]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000184156 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000056258 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 "Entrez Gene: KCNQ3 potassium voltage-gated channel, KQT-like subfamily, member 3".
  6. Nardello R, Mangano GD, Miceli F, Fontana A, Piro E, Salpietro V (December 2020). "Benign familial infantile epilepsy associated with KCNQ3 mutation: a rare occurrence or an underestimated event?". Epileptic Disorders. 22 (6): 807–810. doi:10.1684/epd.2020.1221. PMID   33337327.
  7. Sands TT, Miceli F, Lesca G, Beck AE, Sadleir LG, Arrington DK, et al. (August 2019). "Autism and developmental disability caused by KCNQ3 gain-of-function variants". Annals of Neurology. 86 (2): 181–192. doi:10.1002/ana.25522. hdl: 2078.1/224457 . PMID   31177578.
  8. Arredondo K, Myers C, Hansen-Kiss E, Mathew MT, Jayaraman V, Siemon A, et al. (May 2022). "Phenotypic Spectrum in a Family Sharing a Heterozygous KCNQ3 Variant". Journal of Child Neurology. 37 (6): 517–523. doi:10.1177/08830738221089741. PMID   35384780.
  9. Yus-Nájera E, Muñoz A, Salvador N, Jensen BS, Rasmussen HB, Defelipe J, et al. (2003). "Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation". Neuroscience. 120 (2): 353–364. doi:10.1016/S0306-4522(03)00321-X. PMID   12890507. S2CID   38381189.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.